Back
Biomarin Pharmaceutical Vs. Merck & Industry Stock Comparison
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
$64.86
Seasonality Move:
-1.74%
Sell
15
MRK
Merck &
Last Price:
$83.01
Seasonality Move:
2.61%
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $64.85. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $64.85The current trend is relatively stagnant and BMRN is experiencing slight buying pressure.
MRK Stock Price Chart
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 53.62 | Buy |
Chaikin Money Flow: | 357106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.89 - 65.05) | Buy |
Bollinger Bands (100): | (63.61 - 68.99) | Sell |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.92 | Sell |
Relative Strength Index (14 RSI): | 21.34 | Sell |
Chaikin Money Flow: | -7951094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.39 - 100.07) | Sell |
Bollinger Bands (100): | (94.54 - 108.38) | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.33 | Buy |
20-day SMA: | 63.28 | Buy |
50-day SMA: | 64.87 | Sell |
200-day SMA: | 74.82 | Sell |
8-day EMA: | 64.3 | Buy |
20-day EMA: | 64.03 | Buy |
50-day EMA: | 64.96 | Sell |
200-day EMA: | 73.2 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.38 | Sell |
20-day SMA: | 92.75 | Sell |
50-day SMA: | 97.29 | Sell |
200-day SMA: | 112.56 | Sell |
8-day EMA: | 86.87 | Sell |
20-day EMA: | 91.3 | Sell |
50-day EMA: | 96.1 | Sell |
200-day EMA: | 107.19 | Sell |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.97 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.38 per share, and an increase next year of $0.91 per share.
Biomarin Pharmaceutical Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |